Orthocell Ltd (OCC) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.211x

Based on the latest financial reports, Orthocell Ltd (OCC) has a cash flow conversion efficiency ratio of -0.211x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-3.07 Million ≈ $-2.17 Million USD) by net assets (AU$14.57 Million ≈ $10.31 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Orthocell Ltd for the company's overall valuation and market capitalisation.

Orthocell Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Orthocell Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Orthocell Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Orthocell Ltd ranked by their cash flow conversion efficiency. See Orthocell Ltd (OCC) cash flow to debt to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Ambra SA WAR:AMB	0.218x
Jalles Machado S/A SA:JALL3	0.155x
QINGCI GAMES INC. -00001 F:Z56	N/A
De Licacy Industrial Co Ltd TW:1464	0.054x
COMMERCIAL SYN BAGS ORD (BSE) NSE:COMSYN	0.024x
VenueG Co. Ltd KQ:019010	0.012x
ISC Fresh Water Investment SOCIMI SA MC:YISC	0.120x
West Wits Mining Ltd AU:WWI	-0.096x

Annual Cash Flow Conversion Efficiency for Orthocell Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Orthocell Ltd from 2013 to 2025. View Orthocell Ltd stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$14.57 Million ≈ $10.31 Million	AU$-8.68 Million ≈ $-6.14 Million	-0.596x	+58.47%
2024-06-30	AU$4.53 Million ≈ $3.21 Million	AU$-6.51 Million ≈ $-4.60 Million	-1.435x	-160.48%
2023-06-30	AU$6.15 Million ≈ $4.35 Million	AU$14.59 Million ≈ $10.33 Million	2.373x	+475.40%
2022-06-30	AU$9.90 Million ≈ $7.01 Million	AU$-6.26 Million ≈ $-4.43 Million	-0.632x	-130.23%
2021-06-30	AU$16.87 Million ≈ $11.94 Million	AU$-4.63 Million ≈ $-3.28 Million	-0.275x	-9.18%
2020-06-30	AU$20.90 Million ≈ $14.79 Million	AU$-5.26 Million ≈ $-3.72 Million	-0.251x	+35.49%
2019-06-30	AU$10.72 Million ≈ $7.59 Million	AU$-4.18 Million ≈ $-2.96 Million	-0.390x	+80.09%
2018-06-30	AU$2.37 Million ≈ $1.68 Million	AU$-4.64 Million ≈ $-3.29 Million	-1.958x	-159.49%
2017-06-30	AU$4.71 Million ≈ $3.33 Million	AU$-3.56 Million ≈ $-2.52 Million	-0.754x	-10.96%
2016-06-30	AU$4.88 Million ≈ $3.46 Million	AU$-3.32 Million ≈ $-2.35 Million	-0.680x	-7.70%
2015-06-30	AU$4.38 Million ≈ $3.10 Million	AU$-2.77 Million ≈ $-1.96 Million	-0.631x	+97.26%
2014-06-30	AU$76.19K ≈ $53.91K	AU$-1.75 Million ≈ $-1.24 Million	-23.009x	-8434.14%
2013-06-30	AU$1.08 Million ≈ $762.57K	AU$-290.57K ≈ $-205.60K	-0.270x	--

About Orthocell Ltd

AU:OCC Australia Biotechnology

Market Cap

$132.46 Million

AU$187.20 Million AUD

Market Cap Rank

#18205 Global

#553 in Australia

Share Price

AU$0.69

Change (1 day)

-0.72%

52-Week Range

AU$0.69 - AU$1.53

All Time High

AU$1.75